• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗炎干预措施——哪些已见成效、哪些未见成效以及未来可能有效的措施。

Anti-inflammatory interventions-what has worked, not worked, and what may work in the future.

作者信息

Fattahi Fatemeh, Ward Peter A

机构信息

Department of Pathology, University of Michigan Medical School, Ann Arbor, Mich.

Department of Pathology, University of Michigan Medical School, Ann Arbor, Mich.

出版信息

Transl Res. 2016 Jan;167(1):1-6. doi: 10.1016/j.trsl.2015.08.003. Epub 2015 Aug 14.

DOI:10.1016/j.trsl.2015.08.003
PMID:26323016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5062739/
Abstract

Our Introductory Commentary relates to many topics that are linked to inflammatory responses and how these responses are regulated in order to promote healing of damaged tissues and bring about effective clearance of infectious agents. In non-infectious situations, cells and tissues release products (danger associated molecular patterns) that can trigger damaging inflammatory responses. These products must be effectively dealt with in order to avoid serious tissue injury. We provide a perspective about many decades of research into the inflammatory response and describe strategies that have achieved success in restraining inflammatory responses, as well as many approaches that have not been clinically effective. With development of new technologies such as advanced genomic analysis, highly sensitive and sophisticated mass spectrometry and related approaches, as well as the ability to employ mutagenesis induction, we are beginning to define highly sophisticated molecular pathways that previously were opaque. This progress may well have clinical relevance, and we may be on the edge of a scientific revolution in the broad area of inflammation.

摘要

我们的引言评论涉及许多与炎症反应相关的主题,以及这些反应如何被调节以促进受损组织的愈合并实现感染因子的有效清除。在非感染情况下,细胞和组织会释放可引发破坏性炎症反应的产物(危险相关分子模式)。必须有效处理这些产物以避免严重的组织损伤。我们提供了关于数十年来炎症反应研究的观点,并描述了在抑制炎症反应方面取得成功的策略,以及许多尚未在临床上有效的方法。随着先进基因组分析、高灵敏度和精密质谱等新技术以及诱变诱导能力的发展,我们开始定义以前不明确的高度复杂的分子途径。这一进展很可能具有临床相关性,并且我们可能正处于炎症广泛领域科学革命的边缘。

相似文献

1
Anti-inflammatory interventions-what has worked, not worked, and what may work in the future.抗炎干预措施——哪些已见成效、哪些未见成效以及未来可能有效的措施。
Transl Res. 2016 Jan;167(1):1-6. doi: 10.1016/j.trsl.2015.08.003. Epub 2015 Aug 14.
2
[Inflammation and non-steroid anti-inflammatory agents].[炎症与非甾体抗炎药]
Tidsskr Nor Laegeforen. 1981 Aug 10;101(22):1213-5.
3
[Different effects of steroidal and non-steroidal anti-inflammatory agents on inflammation].[甾体类和非甾体类抗炎药对炎症的不同作用]
Reumatizam. 1979;26(6):207-14.
4
[Inflammatory reaction. Clinical and biological aspects--practice guidelines].[炎症反应。临床与生物学方面——实践指南]
Rev Prat. 2003 Jun 15;53(12):1371-80.
5
Editorial: Treatment of atherosclerosis as an inflammatory disease.社论:将动脉粥样硬化作为一种炎症性疾病进行治疗。
Curr Pharm Des. 2012;18(28):4265.
6
[Present-day views on the pathomechanism of inflammations and the action of non-steroid anti-inflammatory agents].[关于炎症发病机制及非甾体抗炎药作用的现代观点]
Postepy Hig Med Dosw. 1973 May-Jun;27(3):255-94.
7
Inflammation and cancer: new targets and novel therapeutic approach.炎症与癌症:新靶点与新型治疗方法
Curr Pharm Des. 2012;18(26):3829-30. doi: 10.2174/138161212802083671.
8
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.抑郁症中的炎症反应及抗炎治疗的潜力
Curr Neuropharmacol. 2016;14(7):732-42. doi: 10.2174/1570159x14666151208113700.
9
[Possibilities of allergic inflammation control in patients with bronchial asthma].[支气管哮喘患者过敏性炎症控制的可能性]
Pneumonol Alergol Pol. 2002;70 Suppl 1:81-7.
10
Positioning dual inhibitors in the treatment of pain and inflammatory disorders.双重抑制剂在疼痛和炎症性疾病治疗中的定位。
Inflammopharmacology. 2008 Feb;16(1):1-15. doi: 10.1007/s10787-006-1604-7.

本文引用的文献

1
Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction.将炎症与胰岛素抵抗及β细胞功能障碍联系起来的分子和细胞机制。
Transl Res. 2016 Jan;167(1):228-56. doi: 10.1016/j.trsl.2015.08.011. Epub 2015 Sep 5.
2
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease.哮喘和慢性阻塞性肺疾病的靶向抗炎疗法。
Transl Res. 2016 Jan;167(1):192-203. doi: 10.1016/j.trsl.2015.08.004. Epub 2015 Aug 20.
3
Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence.靶向肠-肝轴治疗非酒精性脂肪性肝炎:转化医学及临床证据
Transl Res. 2016 Jan;167(1):116-24. doi: 10.1016/j.trsl.2015.08.002. Epub 2015 Aug 12.
4
Therapeutics targeting inflammation in the immune reconstitution inflammatory syndrome.针对免疫重建炎症综合征中炎症的治疗方法。
Transl Res. 2016 Jan;167(1):88-103. doi: 10.1016/j.trsl.2015.07.010. Epub 2015 Aug 7.
5
Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.结肠和胃肠道癌症中炎症及色氨酸代谢的治疗靶点
Transl Res. 2016 Jan;167(1):67-79. doi: 10.1016/j.trsl.2015.07.003. Epub 2015 Aug 3.
6
Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.炎症作为心肌梗死的治疗靶点:从过去的失败中汲取教训以应对未来挑战。
Transl Res. 2016 Jan;167(1):152-66. doi: 10.1016/j.trsl.2015.07.002. Epub 2015 Jul 17.
7
Inflammatory targets of therapy in sickle cell disease.镰状细胞病的炎症治疗靶点。
Transl Res. 2016 Jan;167(1):281-97. doi: 10.1016/j.trsl.2015.07.001. Epub 2015 Jul 11.
8
Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease.人类自身免疫及自身免疫病小鼠模型中的干扰素调节因子5
Transl Res. 2016 Jan;167(1):167-82. doi: 10.1016/j.trsl.2015.06.018. Epub 2015 Jul 4.
9
Targeting inflammation in metabolic syndrome.针对代谢综合征中的炎症
Transl Res. 2016 Jan;167(1):257-80. doi: 10.1016/j.trsl.2015.06.017. Epub 2015 Jul 3.
10
Therapeutics targeting persistent inflammation in chronic kidney disease.针对慢性肾脏病持续性炎症的治疗方法。
Transl Res. 2016 Jan;167(1):204-13. doi: 10.1016/j.trsl.2015.06.012. Epub 2015 Jun 25.